Gilead Sciences (GILD) Earnings Date, Estimates & Call Transcripts $165.61 +6.41 (+4.03%) Closing price 04:00 PM EasternExtended Trading$169.35 +3.74 (+2.26%) As of 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFDA EventsFinancialsInsider TradesNews and TrendsOptions ChainOwnershipSEC FilingsShort Interest Gilead Sciences Earnings Summary Gilead Sciences issued Q3 2026 earnings on October 29, 2026, reporting an EPS of $2.55, which beat analysts' consensus estimates of $2.19 by $0.36. Quarterly revenue rose 6.8% year-over-year to $8.30 billion, above analyst estimates of $7.80 billion. With a trailing EPS of -$2.67, Gilead Sciences' earnings are expected to grow next year, from ($0.48) to $9.94 per share. Latest Q3 Earnings DateOct. 29EstimatedConsensus EPS (Oct. 29) $2.19 Actual EPS (Oct. 29) $2.55 Beat By $0.36 Actual Revenue (Oct. 29) $8.30BQ3 2026 Earnings ResourcesQ3 2026 Earnings ReportConference Call Transcript & Audio Slide Deck Press Release (8-K)Slide DeckFull Screen Slide DeckPowered by Get Gilead Sciences Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Gilead Sciences and other key companies, straight to your inbox. Sign Up View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Charts & View Estimated and Actual Earnings DataGILD Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.GILD Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Gilead Sciences Analyst EPS Estimates & Company GuidanceLow, high and average are individual analyst estimates we track. Guidance columns are the company's own outlook, and the revenue estimate was recorded when that guidance was issued.QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany EPS GuidanceCompany Revenue GuidanceRevenue Estimate at GuidanceQ1 20261$1.74$1.74$1.74Q2 20261-$6.99-$6.99-$6.99Q3 20261$1.93$1.93$1.93Q4 20261$2.14$2.14$2.14FY 20264-$1.18-$1.18-$1.18Q1 20271$2.09$2.09$2.09Q2 20271$2.24$2.24$2.24Q3 20271$2.43$2.43$2.43Q4 20271$2.60$2.60$2.60FY 20274$9.36$9.36$9.36Q1 20281$2.14$2.14$2.14Q2 20281$2.31$2.31$2.31 Gilead Sciences Earnings History by Quarter 10/29/2024 - 10/29/2026 Report Date Report Date From Report Date To 3M6MYTD1Y2Y3Y5Y10Y More filters Fewer filters Done 0 Results Export DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails10/29/2026Q3 2026$2.19$2.55+$0.36$1.94$7.80B$8.30B8/3/2026Q2 2026-$7.25-$6.75+$0.50-$8.45$7.40B$7.80B5/7/2026Q1 2026$1.91$2.03+$0.12$1.61$6.91B$6.96B2/10/2026Q4 2025$1.83$1.86+$0.03$1.74$7.68B$7.93B10/30/2025Q3 2025$2.16$2.47+$0.31$2.43$7.42B$7.77B8/7/2025Q2 2025$1.96$2.01+$0.05$1.55$6.95B$7.08B4/24/2025Q1 2025$1.77$1.81+$0.04$1.04$6.77B$6.67B2/11/2025Q4 2024$1.67$1.90+$0.23$1.42$7.15B$7.54B11/6/2024Q3 2024$1.58$2.02+$0.44$3.04$7.01B$7.55B Gilead Sciences Earnings - Frequently Asked Questions When is Gilead Sciences' earnings date? Gilead Sciences has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, October 29th, 2026 based off last year's report dates. Learn more on GILD's earnings history. What guidance has Gilead Sciences issued on next quarter's earnings? Gilead Sciences issued an update on its FY 2026 earnings guidance on Tuesday, August, 4th. The company provided EPS guidance of -0.650--0.300 for the period, compared to the consensus earnings per share estimate of -0.790. The company issued revenue guidance of $30.1 billion-$30.4 billion, compared to the consensus revenue estimate of $30.5 billion. Did Gilead Sciences beat their earnings estimates last quarter? In the previous quarter, Gilead Sciences (NASDAQ:GILD) reported $2.55 earnings per share (EPS) to beat the analysts' consensus estimate of $2.19 by $0.36. Learn more on analysts' earnings estimate vs. GILD's actual earnings. How can I listen to Gilead Sciences' earnings conference call? The conference call for Gilead Sciences' latest earnings report can be listened to online. Listen to Conference Call How can I read Gilead Sciences' conference call transcript? The conference call transcript for Gilead Sciences' latest earnings report can be read online. Read Transcript How much revenue does Gilead Sciences generate each year? Gilead Sciences (NASDAQ:GILD) has a recorded annual revenue of $30.46 billion. How much profit does Gilead Sciences generate each year? Gilead Sciences (NASDAQ:GILD) has a recorded net income of $8.51 billion. GILD has generated -$2.67 earnings per share over the last four quarters. What is Gilead Sciences' EPS forecast for next year? Gilead Sciences' earnings are expected to grow from ($0.48) per share to $9.94 per share in the next year. More Earnings Resources from MarketBeat Related Companies AMGN Earnings Date LGND Earnings Date MRNA Earnings Date REGN Earnings Date VIR Earnings Date VRTX Earnings Date ABBV Earnings Date BMY Earnings Date MRK Earnings Date PFE Earnings Date Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles Where's the Beef? Trian-Led Buyout Proposal Values Wendy's at $1.4B, But Is It Enough?Alphabet’s Cloud Is Paying Off—But the Bill for Building It Keeps GrowingPlugging In: Vertiv Cashes In On AI DemandGE Vernova’s Reservations Are Turning Into Real Orders—But the Market Still Wants More.Phillips 66 Posts Strong Earnings But the Stock Doesn't CareConstellation Energy's Nuclear Expansion Gets a $5 Billion Opening, Not a GuaranteeVisa's Toll Booth Keeps Collecting, But the Price Is Rising Earnings data for NASDAQ:GILD is sourced from Fiscal.ai, with the most recent quarter reported on 10/29/2026. New results are added as companies report their earnings. From Our PartnersFinancial legend: “This is bad, really bad...”Dr. Martin D. Weiss has publicly predicted six major American market crashes over his 55-year career, each war...Weiss Ratings | SponsoredThe "velvet rope" stock setups hiding from regular indicatorsK.I.R.A. is a new trading engine built to flag market setups before they show up on standard charts. Former...The TradingPub | SponsoredThe investigation Porter spent tens of thousands to documentPorter Stansberry flew the Porter and Co. team 3,300 miles to Dublin to investigate a 17-year investing experi...Porter & Company | SponsoredA free stock pick, from me to youElon's paid this chip supplier since 2012. When NVIDIA tried to buy the company, he fought the deal. Withou...Behind the Markets | SponsoredLast note from me on thisJoel Peterson's free workshop breaks down a three step, three color system that works across stocks, ETFs, gol...The Cycle Code | SponsoredElon Musk's Intel Deal Already Jumped 177 Percent This YearElon Musk's April 2026 partnership with Intel sent shares climbing 177% within two months. Jeff Brown, the ...Brownstone Research | SponsoredYour book attachedBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredManagement just bought 2.8 million sharesManagement just backed a $100 million buyback, repurchasing 2.8 million shares at an average price of $35.26 i...Monument Traders Alliance | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Gilead Sciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Gilead Sciences With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
